References
- Wisniak J, Thomas Graham. I. Contribution to thermodynamics, chemistry, and the occlusion of gases, Education Quimica, 2013; 24(3):316-325
- Henderson LW, A Tribute to Willem Johan Kolff, M.D., 1912–2009, JASN, 2009; 20(5): 923-924
- Gyavali B, Ramakrishna K, Dhamon AS, Sepsis: The evolution in definition, pathophysiology, and management, SAGE Open Medicine, 2019, 7:1-13
- Al-Fares A, Pettenuzzo T, Del Sorbo L, Extracorporeal life support and systemic inflammation, Intensive Care Medicine Experimental 2019, 7(Suppl 1):46, doi: 10.1186/s40635-019-0249-y
- Cruz DN, Antonelli M, Fumagalli R et al, Early use of Polymyxin-B hemoperfusion in abdominal septic shock. The EUPHAS randomized controlled trial, JAMA, 2009; 301(23):2445-2452
- Cutuli SL, Artigas A, Fumagalli R et al, Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry, Annals of Intensive Care, 2016, 6(77) doi.org/10.1186/s13613-016-0178-9
- Payen DM, Guilhot J, Launey Y et al, Early use of a polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized trial, Intensive Care Medicine, 2015, 41(6):975-984
- Bonavia A, Groff A, Karamchandani K, Singbartl K, Clinical utility of extracorporeal cytokine hemoadsorbtion therapy: a literature review, Blood Purif, 2018, 46:337-349
- Napp Cl, Ziegeler S, Kindgen-milles D, Rationale of hemoadsorbtion during extracorporeal membrane oxygenation support, Blood Purif, 2019, 48:203-214
- Mehta Y, Mehta C, Kumar A et al, Experience with hemoadsorbtion (CytoSorb) in the management of septic shock patients, World J Crit Care Med, 2020, 9(1):1-12
- Schadler D, Pausch C, Heise D et al, The effect of a novel extracorporeal cytokine hemoadsorbtion device on IL-6 elimination in septic patients: A randomized controlled trial, Plos One, 2017, 12(10):e0187015
- Honore PM, De Bels D, Gutierrez LB, Spapen HD, Hemoadsorbtion therapy in the critically ill: solid base but clinical haze, Ann. Intensive Care, 2019, 9:22, doi.org/10.1186/s13613-019-0491-1
- Lumlertgul N, Srisawat N, The haemodynamic effect of oxiris haemofilter in septic shock patients requiring renal support: a single center experience, The International Journal of Artificial Organs, 2020, doi: 10.1177/0391398820917150
- Broman ME, Hansson F, Vincent JL, Bodelsson M, Endotoxin and cytokine reducing properties of the Oxiris membrane in patients with septic shock: a randomized crossover double-blind study, PLoS One, 2019, 14(8):e0220444, doi: 10.1371/journal.pone.0220444
- Schwindenhammer V, Girardot T, Chaulier K et al, Oxiris use in septic shock: Experience of Two French Centres, Blood Purif. 2019;47 Suppl 3:1-7. doi: 10.1159/000499510.
- Malard B, Lambert C, Kellum JA, In vitro comparison of the adsorbtion of inflammatory mediators by blood purification devices, Intensive Care Medicine Experimental, 2018, 6:12, https://doi.org/10.1186/s40635-018-0177-2
- Ankawi G, Neri M, Zhang J et al, Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls, Critical Care, 2018, 22:262